A pharmacokinetic and pharmacodynamic study of drug–drug interaction between ginsenoside Rg1, ginsenoside Rb1 and schizandrin after intravenous administration to rats
Author:
Funder
National Basic Research Program of China
Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference48 articles.
1. Panax ginseng extract rich in ginsenoside protopanaxatriol offers combinatorial effects in nitric oxide production multiple signaling pathways;Ahn;Springerplus,2013
2. CYP3A catalyses schizandrin biotransformation in human, minipig and rat liver microsomes;Cao;Xenobiotica,2010
3. Pharmacokinetics, tissue distribution, metabolism, and excretion of ginsenoside Rg1 in rats;Feng;Arch. Pharm. Res.,2010
4. Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes;Fong;Planta Med.,2007
5. Ginsenoside Rg1 inhibits vascular intimal hyperplasia in balloon-injured rat carotid artery by down-regulation of extracellular signal-regulated kinase 2;Gao;J. Ethnopharmacol.,2011
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identifying biomarkers of ginseng medicines with different natures on heart failure;Journal of Ethnopharmacology;2024-07
2. Quality Control of Chinese Medicines Using UPLC–MS;Quality Control of Chinese Medicines;2024
3. Pharmacokinetics Study and Simultaneous Quantification of Eight Schisandra Lignans in Normal Rats by LC-MS/MS after Oral Administration of Schisandra Lignan Extract;Current Pharmaceutical Analysis;2023-09
4. Pharmacokinetic Comparison of Nine Bioactive Compounds of Guanxinshutong Capsule in Normal and Acute Myocardial Infarction Rats;European Journal of Drug Metabolism and Pharmacokinetics;2022-06-25
5. A Comprehensive Review of the Main Lignan Components of Schisandra chinensis (North Wu Wei Zi) and Schisandra sphenanthera (South Wu Wei Zi) and the Lignan-Induced Drug-Drug Interactions Based on the Inhibition of Cytochrome P450 and P-Glycoprotein Activities;Frontiers in Pharmacology;2022-03-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3